Skip to main content

Computer Methods and Programs in Biomedicine Impact Factor

The current CMPB impact factor, its official source boundary, and a practical test for whether a computational-biomedicine manuscript fits the journal.

Editorial processThe Manusights editorial team researches and maintains these guides using source review, field-specific analysis, and our documented editorial process.How we work

Journal evaluation

Want the full journal picture?

See scope, selectivity, submission context, and what editors actually want before you decide whether the journal is realistic.

Open Journal GuidePrivate API processing. Your manuscript is not used to train models.Run my Free Readiness Scan

Quick answer: The current ScienceDirect page for Computer Methods and Programs in Biomedicine displays an impact factor of 6.4 and a CiteScore of 11.9. Record those as publisher-displayed values with an access date; do not invent a metric year the page does not label. The impact factor describes a journal-level citation environment. It does not predict acceptance or prove that a manuscript fits CMPB.

Evidence basis: We reviewed the current Elsevier and ScienceDirect journal home, aims-and-scope, author-guide, and journal-description surfaces on September 11, 2026. Publisher pages control the current journal facts. The fit tests and decision matrices below are Manusights editorial analysis, not an Elsevier acceptance model.

Test whether the computational method and biomedical evidence belong together before using the metric as a reason to submit.

CMPB impact factor at a glance

Item
Current source-bounded value
Impact factor
6.4 on the current ScienceDirect journal surface
CiteScore
11.9 on the current ScienceDirect journal surface
ISSN
0169-2607
Publisher
Elsevier
Core domain
Computing methods and software systems for biomedical research and medical practice
Companion title
Computer Methods and Programs in Biomedicine Update

The two citation metrics use different source databases, document definitions, and calculation windows. Report them separately. Neither value is an acceptance rate, a paper-level quality score, or a forecast of how often one article will be cited.

Method-to-biomedical-consequence decision matrix

Manuscript center
Evidence that supports CMPB fit
Evidence that remains missing when only a benchmark improves
Clinical prediction or classification
Patient-level splits, leakage control, calibration, uncertainty, and external or temporal validation
A random split and a small accuracy gain
Medical imaging method
Appropriate comparators, acquisition diversity, failure analysis, and a meaningful imaging consequence
One curated dataset with no site or device shift
Biomedical signal processing
Physiological validity, subject-level evaluation, artifact handling, and reproducible preprocessing
A cleaner signal without a biomedical interpretation
Decision-support software
Intended user, workflow location, usable output, reliability limits, and prospective or realistic evaluation
An interface layered over an unvalidated model
Simulation or mechanistic model
Assumptions, sensitivity, parameter identifiability, validation data, and a biomedical inference
A visually plausible simulation without empirical constraint
Reusable biomedical software
Documented implementation, testable availability, versioning, examples, and evidence the software changes research practice
Code mentioned but not inspectable or evaluated

This is the page's main decision artifact. It converts a broad journal metric into the question CMPB editors and readers can actually evaluate: does the computing contribution produce a defensible biomedical method, system, or result?

What the 6.4 impact factor means

The displayed impact factor gives dated context about citations to the journal's recent eligible content. It can help authors compare citation environments after they have already identified journals that genuinely fit the work.

It does not mean that a typical article receives 6.4 citations. Citation distributions are uneven, article types differ, and a journal average cannot resolve whether one manuscript has sufficient novelty or validation. It also cannot tell whether a technically strong model matters to biomedical researchers or medical practice.

For a CV, grant, institutional report, or journal shortlist, retain four fields together: journal title, metric name, displayed value, and access date. Add a data year only when the authoritative surface states one explicitly.

Impact factor trend and source boundary

The reviewed publisher surface supplies a current displayed value, not a year-by-year JIF series. That is not enough evidence to claim that CMPB's impact factor is rising or falling. A defensible trend requires consecutive values from the same metric provider, each tied to its JCR data year and checked for category or calculation changes.

If trend direction matters, retrieve the historical JCR series through an authorized institutional source and preserve the values, years, and access date together. Do not construct a trend by mixing the current publisher display with CiteScore, SJR, or undated directory snippets. Until a consistent series is available, the honest conclusion is current value known; direction not established.

Does the manuscript have a CMPB-shaped contribution?

Write one sentence for every row before choosing the journal.

Test
A strong answer includes
Warning sign
Computing contribution
A method, model, algorithm, or software system that is more than a routine application
A familiar model applied to a new disease label
Biomedical question
A problem whose data-generating process and consequence are understood
A public dataset used only because it is available
Comparator
Current and relevant baselines evaluated under the same information and split rules
Weak or incomparable baselines
Validation unit
Patient, subject, site, device, or time-based separation matched to the intended claim
Row-level leakage or repeated observations crossing folds
Reliability
Calibration, uncertainty, robustness, error modes, or sensitivity appropriate to use
Accuracy presented without failure analysis
Reproducibility
Enough data, code, parameters, and preprocessing detail to test the central result
Critical implementation choices hidden
Biomedical consequence
A clear explanation of what the method lets researchers or practitioners know or do
Clinical language that exceeds the evaluation

A paper can be computationally novel but too disconnected from biomedicine. It can also be clinically interesting while offering little methodological or software contribution. CMPB fit is strongest when both sides of the title, computer methods or programs and biomedicine, are necessary to the claim.

When the metric helps a shortlist

Use the impact factor only after mapping the paper's claim and evidence to plausible journals. Then the metric can provide one dated comparison point among venues that already fit. It is most useful when the author records the source and access date, keeps different metric systems separate, and reviews the number again before a formal report or submission decision.

It is not useful as the first filter for a heterogeneous shortlist. A medical-imaging paper, reusable informatics tool, clinical decision-support study, and general machine-learning method may serve different readers even when every project uses biomedical data. Compare those routes in the journal directory and the biomedical-engineering journal guide, then return to the metric only for the titles that survive the fit test.

This order avoids a common failure: optimizing the venue name while leaving the manuscript's real audience, validation unit, or contribution unresolved. A lower-metric specialist journal can be the stronger destination when it owns the method and reader the paper actually serves.

CMPB versus the open-access companion title

Computer Methods and Programs in Biomedicine Update is a separate companion title. Do not assume that the journals share identical scope, review criteria, access model, or metrics simply because their names overlap.

Compare the live publisher pages when deciding between them:

  • confirm which title owns the manuscript's article type and contribution;
  • verify the current access and fee terms on the correct journal page;
  • check whether the paper's method and evidence depth match the target's current aims;
  • cite metrics only from the corresponding title's own record.

The distinction matters for search as well as submission: this page owns the impact-factor and fit question for the original CMPB title, not CMPB Update.

Readiness check

See how your manuscript scores before you submit.

Run the scan to get a readiness signal before you commit to a journal.

Check my manuscript fitPrivate API processing. Your manuscript is not used to train models.Open journal guide

A reproducibility-first preflight

Before polishing the cover letter, inspect the manuscript in this order:

  1. state the computing contribution without naming the disease or dataset;
  2. state the biomedical consequence without claiming deployment that was not tested;
  3. verify that no patient, subject, site, or temporal leakage inflates the result;
  4. compare against current baselines under equal data and tuning conditions;
  5. expose preprocessing, exclusions, missingness, and label construction;
  6. report uncertainty, error modes, and subgroup or distribution-shift behavior where relevant;
  7. make the implementation or reconstruction path inspectable enough to test the claim.

If steps one and two describe unrelated stories, the manuscript needs conceptual repair before journal targeting. If steps three through seven fail, a higher-impact venue does not solve the evidence problem.

Pressure-test leakage, validation, and claim scope while the evidence can still be changed.

Source-safe metric wording

A defensible note is: “The current ScienceDirect journal surface for Computer Methods and Programs in Biomedicine displays an impact factor of 6.4 and a CiteScore of 11.9, accessed September 11, 2026.”

Avoid these claims:

  • “CMPB's 2026 impact factor is 6.4” unless the publisher labels that metric year;
  • “a 6.4 impact factor means my paper will be cited”;
  • “CiteScore 11.9 confirms the impact factor”;
  • “the impact factor makes CMPB the best journal for this paper.”

The restrained wording is more reproducible. It lets a reader verify the display, understand its date, and avoid mixing two different metrics.

Submit if / think twice if

Consider CMPB if the paper makes a real computing-method or software contribution, tests it with biomedical data under defensible validation, and connects the result to a bounded biomedical research or practice consequence.

Think twice if the main result is a small benchmark gain on a familiar dataset, the biomedical context is decorative, patient or site leakage is possible, deployment claims exceed retrospective evidence, or code and preprocessing choices cannot be inspected.

Check the complete method-to-biomedicine argument before choosing the journal on metric value alone.

Bottom line

Computer Methods and Programs in Biomedicine currently displays an impact factor of 6.4. The number is useful only after the fit question is answered. A credible CMPB paper joins a non-routine computing contribution to leakage-resistant evaluation, reproducibility, and a biomedical consequence that the evidence actually supports.

Frequently asked questions

What is the current CMPB impact factor?

The current ScienceDirect journal surface displays an impact factor of 6.4 for Computer Methods and Programs in Biomedicine. Preserve the publisher label and access date because metric years and display conventions can change.

What is the CMPB CiteScore?

The same publisher surface displays a CiteScore of 11.9. CiteScore and Journal Impact Factor use different databases and calculation windows, so they should be reported separately.

What kind of paper fits CMPB?

A strong candidate joins a non-routine computing method or software contribution to defensible biomedical validation, reproducibility, and a bounded consequence for research or medical practice.

Does the impact factor predict acceptance?

No. A journal-level citation metric cannot measure the novelty, validation, reproducibility, clinical relevance, or editorial fit of an individual manuscript. Those questions require a direct review of the paper's contribution and evidence.

Sources accessed September 11, 2026.

  1. Computer Methods and Programs in Biomedicine journal home, ScienceDirect and Elsevier.
  2. CMPB aims and scope, ScienceDirect and Elsevier.
  3. CMPB guide for authors, ScienceDirect and Elsevier.
  4. Computer Methods and Programs in Biomedicine journal description, Elsevier.

Frequently asked questions

The current ScienceDirect journal surface displays an impact factor of 6.4 for Computer Methods and Programs in Biomedicine. Preserve the publisher label and access date because metric years and display conventions can change.

The current ScienceDirect journal surface displays a CiteScore of 11.9. CiteScore and Journal Impact Factor use different databases and calculation windows, so they should not be combined or treated as interchangeable.

CMPB covers computing methodology and software systems used in biomedical research and medical practice. A strong fit connects a real computational contribution to a defensible biomedical use, evaluation, or insight.

No. A journal-level citation metric does not measure the novelty, validation, reproducibility, clinical relevance, or editorial fit of an individual manuscript.

Before you upload

Want the full journal picture?

Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.

These pages attract evaluation intent more than upload-ready intent.

Private API processing. Your manuscript is not used to train models.

Put the guidance to work

Build a journal decision from more than one signal.

Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.

Internal navigation

Where to go next